Stay updated with breaking news from Foundationone Liquid. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A liquid biopsy test used for molecular profiling in patients with solid tumors also identified patients who were at risk for clonal hematopoiesis, which may develop into myeloid blood cancer.
Toronto, ON (PRWEB) August 18, 2022 -- A liquid biopsy is a simple and non-invasive alternative to surgical biopsies. It has the potential to identify genetic
The Canadian approval follows similar decisions in the US and Japan, and a positive recommendation from the EMA's CHMP.
The LEADER trial will use the firm's FDA-approved FoundationOne CDx and FoundationOne Liquid CDx comprehensive genomic profiling tests.
/PRNewswire/ -- The Liquid Biopsy for Cancer Diagnostics Competitive Landscape and Pipeline report is expected to rise due to an increased prevalence rate of...